CANEX Metals (CANX) Stock Price, News & Analysis

Company Overview

CANEX Metals Inc., a junior exploration company, engages in the acquisition, exploration, and development of mineral properties in Canada and the United States. The company explores for gold and silver deposits. It holds interests in the Gold Range property that consists of 262 lode mining claims and 2 patented claims covering an area of 1650 hectares located in Mohave County, Arizona; and Gibson property covering an area of 887 hectares located in central British Columbia. The company was incorporated in 1971 and is headquartered in Calgary, Canada.

Key Stats

• Today's Range: C$0.05 to C$0.05
• 50-Day Range: C$0.03 to C$0.07
• 52-Week Range: C$0.03 to C$0.08
• Volume: 60,000 shs
• Average Volume: 86,581 shs
• Market Capitalization: C$5.15 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CANX Stock Analysis - Frequently Asked Questions

How have CANX shares performed this year?

CANEX Metals' stock was trading at C$0.05 at the beginning of 2024. Since then, CANX shares have decreased by 10.0% and is now trading at C$0.05.
View the best growth stocks for 2024 here.

How do I buy shares of CANEX Metals?

Shares of CANX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of CANEX Metals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CANEX Metals investors own include Myriad Genetics (MYGN), Acura Pharmaceuticals (ACUR), Akers Biosciences (AKER), Argos Therapeutics (ARGSQ), Bellerophon Therapeutics (BLPH), BioLineRx (BLRX) and Audentes Therapeutics (BOLD).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Basic Materials
• Industry: Gold
• Sub-Industry: N/A
• Current Symbol: CVE:CANX
• CUSIP: N/A
• CIK: N/A
• Web: canexmetals.ca
• Phone: 403-233-2636
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-1,040,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -6.32%
• Return on Assets: -3.20%

Debt

• Debt-to-Equity Ratio: 0.64
• Current Ratio: 43.42
• Quick Ratio: 15.67

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$0.01 per share
• Price / Cash Flow: 3.64
• Book Value: C$0.05 per share
• Price / Book: 0.90

Miscellaneous

• Outstanding Shares: 114,380,000
• Free Float: N/A
• Market Cap: C$5.15 million
• Optionable: Not Optionable
• Beta: 1.19